Phillips, Mark
Rönnblad, Erik
Lopez-Rengstig, Love
Svantesson, Eleonor
Stålman, Anders
Eriksson, Kalle
Ayeni, Olufemi R.
Samuelsson, Kristian
Article History
Received: 5 August 2017
Accepted: 6 February 2018
First Online: 28 February 2018
Compliance with ethical standards
:
: Mark Phillips has received advisory board honoraria from Sanofi and Pendopharm (unrelated to this project). Erik Ronnblad has no financial conflicts of interest to disclose. Love Lopez Rengstig has no financial conflicts of interest to disclose. Eleonor Svantesson has no financial conflicts of interest to disclose. Anders Stalman has no financial conflicts of interest to disclose. Kalle Eriksson has no financial conflicts of interest to disclose. Kristian Samuelsson has no financial conflicts of interest to disclose. Olufemi Ayeni is on the Board for KSSTA, and has received honoraria from ConMed (unrelated to this project).
: Ethical approval was provided for the National database by the Stockholm Regional Ethical Review Board.
: Informed consent was not required for this specific study.